Project Grant R35GM156286
Award Date
2/1/25
Completion Date
1/31/30
Dollars Obligated
$695K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), provides $445,000.00 in funding to the Beckman Research Institute of the City of Hope to conduct research on the role of allostery in the function of G protein-coupled receptors (GPCRs) and trimeric G proteins. The key research objectives include: 1) Dissecting the structural basis of allosteric modulation by the third...
This $416,625 Project Grant, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), will support research to develop innovative optical tools to control endogenous G protein-coupled receptors (GPCRs) in unmodified cells and in vivo, as well as GPCRs and endogenous G proteins at exclusive subcellular locations such as Golgi and nuclear membranes. The project also aims to investigate the molecular links...
This Project Grant award of $410,014 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program aims to establish proof-of-concept for a new high-speed, real-time feedback-driven single particle tracking (RT-FD-SPT) fluorescence microscope with concurrent spectroscopic readout. The goal is to develop an advanced instrument that can track individual growth factors with high spatial and temporal resolution while...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training (CFDA 93.859) program, provides $415,000.00 to Sanford Research to conduct research on the structure and function of G protein-coupled receptors (GPCRs). The research aims to gain a deeper understanding of GPCR signaling pathways and their physiological functions, which are critical for drug development as GPCRs are prime targets. The project...
The National Institute of General Medical Sciences (NIGMS) awarded a $471,019 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Georgia TECH Research Corp, doing business as the Office of Sponsored Programs, for the project "Characterizing Extracellular Glycoproteins and Unraveling Their Functions" from February 1, 2025 to January 31, 2030. This project aims to develop innovative methods to comprehensively analyze glycoproteins on cell surfaces and in the...
The National Institute of General Medical Sciences (NIGMS) has awarded a 5-year, $422,173 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) program to the University of Massachusetts Boston. The grant will fund research to advance the understanding of cellular signaling networks that control key developmental processes, including organ growth and tissue patterning. The research will investigate three specific signaling systems - the receptor tyrosine kinase...
This federal Project Grant award, titled "Harnessing Nanoscale Presentation to Elucidate the Impact of Therapeutic Packaging on Innate Immunity", is funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program. The $408,750 award, effective January 1, 2025 through November 30, 2029, aims to develop synthetic oligonucleotide nanostructures that can precisely program interfacial interactions at immune...
The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Federal Grant Program (CFDA 93.859), awarded a $739,631 Project Grant to Purdue University. The purpose of this 4-year award (August 2024 - June 2028) is to investigate the mechanisms underlying regulation of phospholipase C beta (PLCB) enzymes by heterotrimeric G proteins. The research aims to provide new mechanistic insights into PLCB regulation and identify unique regulatory...
The National Institute of General Medical Sciences (NIGMS) awarded a Project Grant totaling $457,500.00 under the Biomedical Research and Research Training Program (CFDA 93.859) to the University of Massachusetts Boston. The grant, with a performance period from September 17, 2024 to August 31, 2027, aims to systematically identify chemical processes and reactions that show promise when initiated under high hydrostatic pressure (HHP) conditions. The research will involve a combination of...
The National Institute of General Medical Sciences (NIGMS) awarded a $389,211 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to the University of Massachusetts (UMass) Amherst. The grant, which runs from July 2024 to June 2029, will fund research to investigate the biophysical and molecular mechanisms underlying a novel process of "meso-scale gap closure" in tissues undergoing epithelial-mesenchymal transition. The research aims to...